129 Medication Assisted Treatment Protocol

Cambridge University Press
24 April 2020
https://pubmed.ncbi.nlm.nih.gov/32375158/

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial

Drug Alcohol Depend
01 June 2018
https://pubmed.ncbi.nlm.nih.gov/29674251/

Very low dose naltrexone in opioid detoxification: a double-blind, randomized clinical trial of efficacy and safety

Toxicol Res
21 November 2019
https://pubmed.ncbi.nlm.nih.gov/32042711/

Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA (Abstract)

ACS Pharmacol Transl Sci
27 July 2020
https://pubmed.ncbi.nlm.nih.gov/33073190/